• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Alaunos Therapeutics Inc. News

    1,32 $ +13,79% +0,16 $
    In : 1,2345 € | 26.04.24 22:00:00 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A401HW
    ISIN: US98973P2002
    US-Symbol: TCRT
    Typ: Aktie

    Alaunos Therapeutics Inc. News

    28.09.22 - PR Newswire
    Thinking about buying stock in Frontier Communications, Edgio, Alaunos Therapeutics, Heartbeam, or Blue Apron?
    Thinking about buying stock in Frontier Communications, Edgio, Alaunos Therapeutics, Heartbeam, or Blue Apron? PR Newswire
    27.09.22 - PR Newswire
    Thinking about buying stock in Kiora Pharmaceuticals, X4 Pharmaceuticals, Ayala Pharmaceuticals, Aquestive Therapeutics, or Alaunos Therapeutics?
    Thinking about buying stock in Kiora Pharmaceuticals, X4 Pharmaceuticals, Ayala Pharmaceuticals, Aquestive Therapeutics, or Alaunos Therapeutics? PR Newswire
    23.09.22 - PR Newswire
    Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics?
    Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics? PR Newswire
    22.09.22 - PR Newswire
    Thinking about buying stock in FREYR Battery, Palantir Technologies, Carnival Corp, Novavax, or Alaunos Therapeutics?
    Thinking about buying stock in FREYR Battery, Palantir Technologies, Carnival Corp, Novavax, or Alaunos Therapeutics? PR Newswire
    14.09.22 - PR Newswire
    Thinking about buying stock in Caladrius Biosciences, Timber Pharmaceuticals, 89Bio, Alaunos Therapeutics, or SoFi Technologies?
    Thinking about buying stock in Caladrius Biosciences, Timber Pharmaceuticals, 89Bio, Alaunos Therapeutics, or SoFi Technologies? PR Newswire
    07.09.22 - PR Newswire
    Thinking about buying stock in Aquestive Therapeutics, Alaunos Therapeutics, Ardelyx, IVERIC Bio, or Nio?
    Thinking about buying stock in Aquestive Therapeutics, Alaunos Therapeutics, Ardelyx, IVERIC Bio, or Nio? PR Newswire
    25.08.22 - PR Newswire
    Thinking about buying stock in Alaunos Therapeutics, BioSig Technologies, Futu Holdings, Hall of Fame Resort & Entertainment, or Verve Therapeutics?
    Thinking about buying stock in Alaunos Therapeutics, BioSig Technologies, Futu Holdings, Hall of Fame Resort & Entertainment, or Verve Therapeutics? PR Newswire
    10.06.22 - PR Newswire
    Thinking about buying stock in Alaunos Therapeutics, Youdao, New Oriental Education, Paltalk, or Bilibili?
    Thinking about buying stock in Alaunos Therapeutics, Youdao, New Oriental Education, Paltalk, or Bilibili? PR Newswire
    06.10.21 - PR Newswire
    Thinking about buying stock in Acer Therapeutics, Ziopharm Oncology, Nutriband, Ocugen, or Flux Power?
    Thinking about buying stock in Acer Therapeutics, Ziopharm Oncology, Nutriband, Ocugen, or Flux Power? PR Newswire
    05.10.21 - PR Newswire
    Thinking about buying stock in Agrify, Rush Street Interactive, Ocugen, Nine Energy Service, or Ziopharm Oncology?
    Thinking about buying stock in Agrify, Rush Street Interactive, Ocugen, Nine Energy Service, or Ziopharm Oncology? PR Newswire
    07.09.21 - PR Newswire
    Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics?
    Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics? PR Newswire
    14.08.18 - PR Newswire
    SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Ziopharm Oncology, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
    SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Ziopharm Oncology, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
    24.05.18 - The Motley Fool
    Wie wir Krebs besiegen: Hier die Argumente und der Hot Stock Ziopharm Oncology
    Es gibt sensationelle Erfolge bei der Krebsimmuntherapie mit Checkpoint-​Inhibitoren und insbesondere mit T-​Zell-Therapien, die erstaunlich wirksam und zielgerichtet sind. Daher ...
    01.09.17 - The Motley Fool
    Gilead hat noch nicht genug
    Die Investoren bekamen am Montagmorgen eine angenehme Überraschung von Gilead Sciences (WKN:885823). Das große Biotech kündigte Pläne zur Übernahme von Kite ...
    10.01.17 - PR Newswire
    ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens
    ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells ...
    05.08.16 - PR Newswire
    Lifshitz & Miller Law Firm Announces Investigation of American Renal Associates Holdings, Inc., CytRx Corporation, El Pollo Loco Holdings, Inc., EndoChoice Holdings, Inc., Full Circle Capital Corp
    Lifshitz & Miller Law Firm Announces Investigation of American Renal Associates Holdings, Inc., CytRx Corporation, El Pollo Loco Holdings, Inc., EndoChoice Holdings, Inc., Full ...
    15.07.16 - PR Newswire
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ZIOPHARM Oncology, Inc. (ZIOP)
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ZIOPHARM Oncology, Inc. (ZIOP) PR Newswire
    15.07.16 - PR Newswire
    Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ZIOPHARM Oncology, Inc. - ZIOP
    Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ZIOPHARM Oncology, Inc. - ZIOP PR Newswire
    22.12.15 - The Motley Fool
    3 Biotech-Aktien, von denen ich die Finger lasse
    Aktien von Biotech-​Unternehmen sind für ihre rasanten Achterbahnfahrten bekannt; und dies aus gutem Grund: 90% aller Medikamente scheitern bei klinischen Studien am ...
    10.08.15 - PR Newswire
    Intrexon Announces Second Quarter and First Half 2015 Financial Results
    Intrexon Announces Second Quarter and First Half 2015 Financial Results - Record quarterly revenues of $44.9 million and Adjusted EBITDA of $54.4 million - - GAAP net loss of ...

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »